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 Abstract 
Depression is a pervasive mental health disorder worldwide. Although being diagnosed 
with chronic illness exacerbates susceptibility to depression, detection and subsequent 
treatment of comorbid depression in primary care settings remain suboptimal because 
patients with chronic medical disorders are not commonly screened for depression. There 
is a need to initiate proactive measures by implementing routine screening in primary 
care settings. The plan-do-study-act (PDSA) model guided an intervention to establish a 
depression screening practice. This study aimed to determine if the implementation of 
evidence-based screening for depression using the Patient Health Questionnaire-9 (PHQ-
9) tool could increase diagnosis of comorbid depression among patients suffering from 
chronic diseases. Convenience sampling served as the method for selecting healthcare 
records that met the predetermined criteria. Two hundred established patients over 18 
years of age were screened for depression at a primary care clinic in Maryland within a 
10-week period following Diagnostic and Statistical Manual of Mental Disorders (DSM-
IV) criteria. Study participants included 84 (42%) males and 116 (58%) females. Of 
these, 84 (42%) had minimal depression, 57 (29%) had mild depression, 23 (12%) had 
moderate depression, 24 (12%) had moderate-severe depression, and 12 (6%) had severe 
depression. The baseline report from the clinic revealed 0% depression screening 
practices yet the post-project chart review revealed a surprisingly high rate of depression 
diagnosis in 34 (17%) of 200 patients suffering from chronic illnesses. Identification of a 
reliable tool that would be used to screen depression among patients with chronic 
diseases at primary care clinics to mitigate the deleterious effects of depression and 
promote the well-being and health of patients and their families is important. 
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Section 1: Introduction 
People who live with chronic illnesses make many adjustments to their lives 
because chronic diseases can limit their independence, and mobility. They become less 
active and more dependent on others for activities of daily living (Fegg, Kraus, Graw, & 
Bausewein, 2015). Chronic diseases that are associated with depression include cancer, 
stroke, heart problems, diabetes, and osteoporosis (Fegg et al., 2015). Consequently, it is 
crucial that chronic disease management is improved by integrating screening of 
depression. 
The World Health Organization (WHO) claimed that mental disorders including 
depression are global health problems (Thapar et al., 2012). The WHO further predicted 
that by 2030, depression would be a causative factor in more years of life lost due to 
disability than any other type of health condition. Early detection of depression is critical 
because of the heavy burden of suffering that accompanies it. Sometimes, depression 
ends in suicide. There is an emerging bidirectional relationship between depression and 
chronic illness. Comorbid depression does lead to functional impairment, and poor 
outcomes (Thapar et al., 2012). Comorbid depression can invoke feelings of hopelessness 
and helplessness, which can sap the motivation of patients to care for themselves. 
Depressed patients are less likely to adhere to treatment regimens and often end 
up with incomplete recovery (Culpepper, Muskin, & Stahl, 2015). As such, an evidence-
based depression screening tool, the Patient Health Questionnaire-9 (PHQ-9), was 
introduced and served as an integral part of the initial encounter with patients suffering 
from chronic illness at a designated primary care clinic. The significant prevalence of 
depression in patients who have chronic diseases suggested that this is a disorder with the 
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potential to impact the medical outcomes of these patients negatively (Culpepper et al., 
2015). According to findings of research by Kang et al. (2015), the depression rate 
among patients suffering from chronic diseases is significantly higher than that of their 
counterparts who do not suffer from such diseases. The use of an evidence-based 
screening tool with excellent sensitivity such as the PHQ-9 represents a significant step 
toward identifying patients with chronic diseases who are suffering from depression. 
Currently, depression is the second leading cause of disability, adjusted in life years, 
among individuals aged between 15 and 44 years (Voinov, Richie, & Bailey, 2013). 
Depression shortens life expectancy by 25 to 30 years (WHO, 2014). It is evident that 
this health condition can be identified through screening to reduce the risk of disabilities 
that accompanies it. The condition can be identified and treated in primary health care 
settings using antidepressants and psychotherapy regimens that have been reported to be 
effective 80% of the time (WHO, 2012). 
This project highlights the importance of depression screening tools in primary 
care and the need to implement a routine screening for depression among patients with 
chronic illnesses. The goal is to reduce the problem of undiagnosed depression in primary 
care settings. This study not only encourages screening and detection of depression as a 
comorbid condition among individuals with chronic diseases but also encourages (PCPs) 
to discuss the results of such screenings with identified participants and proceed with the 
next intervention to improve patient outcomes; while increasing the number of patients 
receiving treatment in primary care settings. 
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Problem Statement 
Depression is a widespread mental health ailment across the world (WHO, 2014). 
It is also a leading causative factor for disability. This quality improvement project was 
conducted at a suburban primary care clinic located in the eastern region of Maryland. 
The average resident at this location was more at risk of suffering from chronic diseases 
compared to the national average because of disparities in access to health care services 
and preventive resources (National Institute of Mental Health, 2017). Research indicates 
that there is a 15.6% risk of depression among individuals with chronic conditions such 
as asthma, chronic obstructive pulmonary disease (COPD), arthritis, heart disease, and 
osteoporosis (Bhattacharya, Shen, & Sambamoorthi, 2014). Maryland is in the second 
unhealthiest region in the United States (Maryland Department of Health, n.d.). The 
adjusted rate of cardiovascular disease in Maryland by race is 50.3 per 100,000 
populations among African American men, 45.2 among African American women, 34.8 
among Caucasian women, and 33.5 among Caucasian men (Maryland Department of 
Health, n.d.). The adjusted rate for cancer for the entire state among all races is 449.8 per 
100,000 populations; among males of all races, it is 507.5 (Community Care of North 
Carolina, 2015). The adjusted rate for colorectal cancer for the whole state is 14.9; among 
men, it is 21.1, and among women, it is 12.5 (Community Care of North Carolina, 2015). 
The National Institute of Mental Health (2017) has endorsed integrated care for 
mental health into primary care settings because individuals with mental disorders have 
higher rates of chronic physical illnesses. People are more likely to visit a primary care 
setting than a mental health system. If mental disorders are routinely screened for in 
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primary care settings, PCPs can provide care for conditions such as depression and 
anxiety. 
Research has confirmed the claims of the U.S. Preventive Services Task Force 
(USPSTF) that screening improves the accuracy of detection of depression in primary 
care settings (Siu, 2016). The USPSTF further reported that nine clinical trials were 
conducted that addressed screening in adults, with results adequate to establish the 
benefits of the treatment of depression (e.g., initiating antidepressants and 
psychotherapy). Screening for depression was found to significantly improve overall 
health outcomes (Culpepper et al., 2015). 
The quality improvement project holds significance for nursing practice. Due to 
the increase of health care coverage through the affordable health care program, many 
patients view primary care clinics as more convenient and reasonable than going to the 
emergency room (U.S. Preventive Services Task Force, 2014). Thus, introducing routine 
depression screening practice in this primary care setting was ideal for this population. 
Patients diagnosed with chronic diseases such as cancer, hypertension, stroke, arthritis, 
diabetes, heart disease, and chronic lung disease are more likely to be at risk for 
depression than their counterparts (Wu, 2013). 
With the introduction of an evidence-based depression screening tool at the 
designated primary care practice, the detection of depression risks in this population 
group was increased. The proposed routine screening practice served as an integral part 
of an initial encounter for patients suffering from chronic illnesses in the primary care 
setting. This doctoral project was necessary because research findings indicated that the 
number of American people receiving mental health care from PCPs was increasing 
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(Olsen, 2014). This doctoral project endeavored to demonstrate that there is a need to 
introduce screening for depression among patients with chronic diseases in primary care 
settings where depression screening practices are lacking. 
Purpose Statement and Project Objectives 
The goal of this quality improvement project was to determine if the 
implementation of an evidence-based depression screening tool could improve early 
identification and detection of comorbid depression among patients suffering from 
chronic diseases at a primary care clinic located in Maryland. The project applied the 
PDSA model as the framework to establish a routine depression screening practice in the 
clinic. 
The project objective was to close an existing gap at the host primary care clinic 
in Maryland. Research showed that two-thirds of all adults seen in primary care remain 
undiagnosed with depression (Pence, O’Donnell, & Gaynes, 2013). This project fostered 
early detection of comorbid depression among patients with chronic diseases following 
implementation of routine screening for depression in this primary care setting. The 
project enhanced the roles played by nurses as leaders to bring forward screening projects 
in a primary care setting. 
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Section 2: Background and Context 
Practice Knowledge Gap 
This quality improvement project was conducted at a suburban primary care clinic 
located in the eastern region of Maryland. The clinic had primary care health personnel 
including a physician, a nurse practitioner, a physician assistant, a registered nurse, and 
three certified medical assistants. This clinic was known to offer high-quality health care 
services with respect, and compassion to patients and their families. The practice had 
been in existence for over 10 years. The clinic served its entire community, managing 
patients with a broad range of acute and chronic diseases. The clinic had no routine 
depression screening practices in place. 
Despite the PCPs’ expertise in managing an array of health conditions at the clinic 
site, their patients were not getting screened for depressive symptoms. Evidence 
supporting this discovery came from the clinic’s data baseline report that revealed 0% of 
depression screening practices and the absence of depression screening documentation in 
electronic patient charts. It was essential to implement a reliable tool to screen depression 
in patients with chronic diseases at this primary care clinic. The patient population was 
considered vulnerable due to low educational status, financial problems, and lack of 
health insurance. 
Research findings continue to reveal higher depression risks in individuals 
suffering from renal disease, heart disease, and chronic arthritic disease (Chiang, Livneh, 
Yen, Li, & Tsai, 2013). Even among ambulatory patients who use primary care services 
for health maintenance for chronic disease management, research has indicated that there 
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is a significantly high rate of depression that has not been diagnosed, recognized, or 
treated appropriately (Chiang et al., 2013). 
Significance and Relevance to Practice 
The primary care clinic’s health personnel (a physician, a nurse practitioner, a 
physician assistant, a registered nurse, and three medical assistants) were involved in the 
screening program. Because depression is an insidious disease that can afflict anyone, 
participants included adults aged 18 and older in the state of Maryland. Routine screening 
can improve early detection, and accurate identification of individuals suffering from 
depression, which can reduce potential morbidity (Rankin et al., 2015). Screening can 
impact clinicians by helping them to identify risks and make appropriate diagnoses to 
initiate treatment or refer patients to proper resources, and thus improve the quality of 
patient care, and health outcomes in their practices. 
Project Question 
The project question used to guide data collection, data analysis, result 
examination, and outcomes was the following: In the State of Maryland, at a designated 
primary care clinic site, does the implementation of evidence-based screening for 
depression, using a PHQ-9 tool within the context of the PDSA Cycle, increase diagnosis 
of depression? 
Evidence-Based Significance of the Project 
The depression screening project used the PHQ-9 as the instrument to screen 
participants for depressive symptoms. The PHQ-9 is a multipurpose instrument that can 
be used in practice to screen and diagnose depression. It has a depression module scoring 
each of the nine criteria from the fourth edition of the Diagnostic and Statistical Manual 
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of Mental Disorders (DSM-IV), such as 0 -not at all to 3 -nearly every day; (Maurer, 
2012). The PHQ-9 can be used to make diagnoses of depression in at-risk population 
groups. A score > 10 on the PHQ-9 is considered a positive screen for depression. The 
instrument has 61% sensitivity and 94% specificity in adults (Maurer, 2012). It was 
found to have good internal consistency and to be reliable and valid in prior research 
(Arrieta et al., 2017; Gelaye et al., 2013). The instrument was developed and assessed 
using traditional psychometric qualities underpinned by classical test theory (CTT; 
Horton & Perry, 2016). 
Implications for Social Change in Practice 
This project had positive implications for social change as its motive was to 
introduce and integrate an evidence-based routine screening for depression, which 
facilitated appropriate and timely diagnosis for identified patients. This social change 
promoted the well-being and health of the participants as well as their families and 
communities at large. There was a need for timely and accurate diagnosis of depression 
that would allow patients to have positive health outcomes and live healthy lives, in 
which they could contribute to their communities in many positive ways. A healthy 
community is a productive community. 
Definition of Terms 
Definitions for the medical terms used in this project were extracted from multiple 
sources. 
Asymptomatic: Not showing any symptoms of a disease (“Asymptomatic,” 2018). 
Comorbid depression: Depression that develops in the presence of another illness 
(“Comorbid Depression,” 2018). 
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Depression: A mood disorder that adversely affects how a person feels, thinks, 
and handles daily activities and social life (“Depression,” 2018). 
Diagnosis: The identification of illness through a screening process and 
examination of symptoms (“Diagnosis,” 2018). 
Mental disorder: A health condition in the form of a behavioral or psychological 
pattern that is a source of the poor ability to function (“Mental Disorder,” 2018). 
Plan-do-study-act (PDSA) model: A systematic series of steps used to gain 
valuable knowledge and skills for continuous quality improvement (Minnesota 
Department of Health, 2018). 
Psychometrics: The psychological measurement of knowledge, attitudes, and 
personal traits (“Psychometrics,” 2018). 
Screening: A method used in a population group to investigate and detect the 
presence of an undiagnosed disease such as depression in a population group whose 
members are asymptomatic using a methodological approach and relevant tool 
(“Screening,” 2018). 
Social change: Any process that alters the behavioral patterns and cultural values 
of a community over time (“Social Change,” 2018). 
Assumptions and Limitations 
The question guiding this project was as follows: In adult patients with chronic 
diseases at a designated primary care clinic in Maryland, will the implementation of an 
evidence-based depression screening tool (PHQ-9) increase the early identification of 
depression in patients when compared to the clinic’s baseline depression screening rate 
before implementation of the project? The project used the depression screening tool 
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(PHQ-9) within the PDSA model to ascertain whether the depression screening tool’s 
implementation would improve early identification of depression in patients in this target 
population group. This evidence-based practice change project helped to highlight the 
benefits of screening for depression at the intervention site. The project identified 
participants who needed a professional collaborative continuum of treatment for 
depression. The project confirmed that people with chronic diseases are at high risk of 
suffering from depression (Centers for Disease Control and Prevention, 2012). 
Weaknesses and Limitations of Research Design 
The evidence-based practice project was intended to increase the detection and 
recognition of depression in patients with chronic diseases at the designated primary care 
clinic. In quantitative studies, in which respondents’ answer a series of questions on a 
questionnaire, there is usually a danger of response bias and recall bias. The use of 
closed-ended questions was dominant in this evidence-based practice change project. 
Unfortunately, closed-ended questions do not give the respondents the opportunity to 
express their opinions or to explain the reasons for their choice of answers. Closed-ended 
questions only allow participants to choose a response. This intervention program also 
had some limitations. Due to project time constraints, I was unable to coordinate with the 
clinic team to follow up with patients diagnosed with depression to determine whether 
the treatment that the patients received was associated with better management of their 
chronic conditions. Further, the limited timeframe after project completion did not allow 
me to collaborate with the clinic team to monitor patients’ adherence to depression 
treatment. 
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Summary 
Screening provides a way to recognize conditions such as depression in patients 
who may be asymptomatic (Thombs et al., 2012). Screening practices are necessary for 
realizing better patient outcomes that are possible when patients are diagnosed at a later 
phase of the disease. To prevent and mitigate the harmful effects of depression among 
people with chronic diseases, healthcare professionals need to take proactive measures to 
diagnose the disorder early through screening practices. Those identified to have 
depression can then be offered presymptomatic treatment, which reduces health care 
costs and increases positive outcomes (DeJean, Giacomini, Vanstone, & Brundisini, 
2013). Mental disorders, including depression, cost the nation $56.0 billion annually 
(Taylor et al., 2015). This screening project alerted clinicians when patients’ mental state 
was likely to affect the treatment of their chronic disease. The clinicians could then 
advocate for their patients and provide the necessary psychological support and other 
resources for them (Hinz et al., 2016). The significance of this project resides in its 
potential to promote accurate and prompt identification and diagnosis of depression in 
patients suffering from chronic diseases, which could reduce potential morbidity and 
associated costs. If depression is left undiagnosed, it can degenerate into a severe medical 
problem that can disrupt families and communities. 
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Section 3: Collection and Analysis of Evidence 
Review of Scholarly Evidence 
The general health of an individual relies heavily on the individual’s 
psychological and mental health condition. Over the last few decades, it has increasingly 
appeared that there is an association between chronic disease and the development of 
depression (Keshavarz et al., 2013). This claim has attracted the attention of many 
researchers who have examined and analyzed the few prior research studies that have 
been conducted to validate this claim; this project was a result of such an examination 
(Keshavarz et al., 2013). It is noteworthy that the review and evaluation of prior research 
have focused on scrutinizing studies about the lack of screening for depression in primary 
care settings. 
Keshavarz et al. (2013) endeavored to conduct a meta-analysis of research carried 
out between 1994 and 2012 retrieved from databases such as MEDLINE, PsycINFO, 
Cochrane Central Register of Controlled Trials, and Cochrane Database of Systematic 
Reviews. The purpose of the study was to establish the benefits of screening for 
depression in average population groups. The conclusion of the meta-analysis 
underscored a dire need to increase early diagnosis of depression and follow-up treatment 
for those diagnosed with the disease as well as those most likely to be affected by it. 
Though the authors had trouble finding studies revealing evidence of the benefits of 
screening, they identified five studies as eligible for their meta-analysis, which made their 
study of great importance. It added to and highlighted an aspect of health care that 
seemed to be marginalized or less explored. Although the studies that Keshavarz et al. 
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identified had few participants, their meta-analysis served to create interest in 
investigating the problem further. 
Crogan and Evans (2012) responded to the need for research to reveal benefits of 
screening for depression among the chronically ill. A two-group prospective quasi-
experimental research study was conducted among long-term-care adults who had 
multiple chronic diseases. The study was a comparative study of the elderly in long-term 
care who underwent routine screening for depression every 6 months and those who were 
only receiving routine care in facilities without being screened for depression. A total of 
81 residents were recruited for the study. Forty of the residents formed a group whose 
members had never been screened for depression, and the rest were from facilities where 
they were assessed every 6 months. Participants’ levels of depression were measured 
using the Geriatric Depression Scale, which is used to assess depression in older adults 
who have mild and moderate cognitive impairment. 
Studies revealed that among the group whose members underwent period 
screening, the diagnosis of depression decreased from 46% to 29% (Keshavarz et al., 
2013). In a similar group that underwent period screening, the Geriatric Depression Scale 
found that there was only a 9.4% decrease in depression among the elderly (Keshavarz et 
al., 2013). These results shed light on the efficacy of regular screening for depression as 
far as reducing levels of depression is concerned. In cases where there is routine 
screening for depression, more cases are identified, which lowers the levels of 
unidentified or undiagnosed depression. It confirms the need for regular screening, 
particularly among vulnerable population groups likely to suffer from chronic diseases. 
Regular screening for depression can result in considerable percentages of people having 
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access to treatment. The weakness of the study is that the sample size was small, and the 
results might not be generalizable to the rest of the community. Moreover, it was 
conducted among residents of facilities that differ from primary care settings. Application 
of the findings to the general public should be done with caution. 
It is not known which chronic diseases are more associated with the development 
of depression. In an effort to address this knowledge gap, Wu (2014) conducted a 
descriptive cross-sectional study of 310 individuals suffering from chronic metabolic 
syndrome to measure the efficacy of screening for depression. Wu used questionnaires 
such as the WHO-5 and PHQ-2 scales. Self-administered questionnaires were used to 
collect data on psychological indices and biochemical tests from respondents. The results 
from the WHO-5 showed that 5% of the participants had depressive symptoms and 1.0% 
were confirmed depression cases (Wu, 2014). The PHQ-2, when administered to the 
same participants, revealed that 4.8% had depression (Crogan & Evans, 2012). These 
findings confirm not only the validity of the tools used to screen for depression but also 
the need for routine screening to identify people suffering from depression so that they 
can be placed in appropriate treatment. It is impossible to give patients treatment for 
depression if they have not been diagnosed. Untreated depression can have tragic 
consequences. The bottom line is that there is a need for sustained screening for 
depression in populations whose members are at high risk for depression. This is the 
reason that this project is of utmost relevance and importance. 
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Concepts 
Chronic Pain 
Pain that emanates from chronic disease can impair activities of daily living and 
interrupt productivity and social life (Banhato, Galil, Campos, Colugnati, & Richter, 
2016). Chronic pain can be a source of insomnia, poor nutrition, and poor appetite 
(Banhato et al., 2016). These factors can lead to depression in patients. Banhato et al. 
(2016) conducted a study among 1,558 participants with multiple chronic conditions at a 
center for management of chronic diseases such as diabetes and chronic kidney diseases 
in Brazil. The study was an attempt to substantiate the potential correlation between 
chronic illness and depression. The study was prompted by an underdiagnosed number of 
cases of depression likely to develop among people with chronic health conditions. The 
authors used a PHQ-2 tool. The research assistants administered the questionnaire to 
participants, and no incentive was given to the participants for their time. Their eligibility 
was determined by the WHO definition of chronic disease. 
The findings by Banhato et al. (2016) suggested a positive correlation between 
suffering from chronic illness and reporting depressive symptoms. It is noteworthy that 
this study did not rely on the DSM-IV for diagnosis of depression. Instead, Banhato et al. 
used epidemiological screen scales. It is necessary to use the DSM-IV to diagnose 
depressive symptoms because this can function as a guideline for determining a treatment 
regimen. To diagnose depression without the prospect of treating it is counterproductive. 
This current research study indicated that depressive symptoms could remain 
undiagnosed and untreated for people with chronic diseases unless a screening program is 
established. Efforts to train health care professionals to identify depressive symptoms 
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accurately among vulnerable population groups and design appropriate treatment 
procedures should precede this. 
Chronic Diseases and Comorbid Conditions 
To explore the findings regarding the association between chronic diseases and 
depression risk several studies have been conducted. One such study was by 
Gerontoukou, Michaelidoy, Rekleiti, and Saridi (2015) who conducted an investigative 
study among 204 patients living in urban areas. These patients underwent treatment at a 
local hospital and were visiting outpatient clinics at that hospital. Gerontoukou et al. 
sought to determine their levels of anxiety and depression and to establish a correlation 
between the results and the patients’ daily activities. The sample consisted of people who 
were suffering from hypertension, diabetes, and hypercholesterolemia. The 
instrumentation used in the study was the Greek version of the Zung Self-Rating 
Depression Scale for assessment of depressive symptoms due to its reported high 
sensitivity, specificity, and repeatability (Gerontoukou et al., 2015). Furthermore, the 
Greek version of the Delusions-Symptoms-States Inventory State of Anxiety and 
Depression Scale (DSSI/sAD) by Bedford, Foulds, and Sheffield (1976) was used in this 
investigative study to assess the level of anxiety and depression of participants. The 
results of the study revealed that 35% of the participants were diagnosed with depression 
and 56% of them were diagnosed with anxiety (Gerontoukou et al., 2015). These results 
indicate a correlation between chronic disease and psychological disorders such as 
depression and anxiety, suggesting that chronic illness does trigger these conditions. The 
U.S. Preventive Services Task Force (2016) has urged health care professionals to 
routinely screen adult populations for depression. Healthcare professionals need to start 
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paying attention to individuals suffering from chronic illnesses as far as depression and 
other psychological conditions are concerned so that those conditions can be treated 
before they progress into potentially tragic developments. 
Conceptual Models and Theoretical Frameworks 
The evidence-based practice model for this improvement project was the PDSA 
model using the PHQ-9 self-reported questionnaire (Institute for Healthcare 
Improvement, 2018). There are four stages in the PDSA model: plan, do, study, and act 
(Institute for Healthcare Improvement, 2018). The use of the PDSA model encouraged 
the drive to integrate screening practices as part of the clinic’s first encounter with 
patients with chronic diseases. The planning phase entailed identification of patients with 
a major depressive disorder, the type of data collected (mild to severe depressive 
symptoms), how data were gathered (PHQ-9), who collected data (the clinic team), when 
data were collected (when patients were waiting to be seen by their primary care provider 
(PCP), and the location where data were gathered in the assigned examination room 
(Institute for Healthcare Improvement, 2018). I initiated this project in collaboration with 
the clinicians of the host primary care setting and rest of the primary care team. 
Another goal of this evidence-based practice change project was to use this model 
as a guide to establish a screening practice for comorbid depression at this intervention 
site for patients with chronic diseases to screen and identify depression early. The PDSA 
model was chosen for this project because of its versatility. PDSA provides a 
straightforward and iterative approach to healthcare delivery practice for quality 
improvement. The model provides a framework that can be adopted by any practice 
regardless of its resources or size. The PDSA model has been chosen and used 
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successfully in many healthcare organizations in which it has served to accelerate change 
and improve quality (Institute for Healthcare Improvement, 2018). 
The PDSA model is also known as the Deming wheel or Deming cycle. This 
concept was first developed by and introduced to Deming by his mentor, Walter 
Shewhart, of the famous Bell Laboratories in New York (Deming Institute, 2016). 
Approach/Methodology 
This quality improvement project was conducted in a suburban primary care 
clinic located in the eastern region of Maryland. The population was mostly African 
American, Indian, and Caucasian. The clinic did not have any patients who required 
bilingual services. Several patients who received care at the clinic received state-run 
health care insurance through the state of Maryland. The clinic was open Monday 
through Friday and provided primary care services to all age groups, with patients 
ranging from the pediatric to the geriatric population. The health care providers at the 
clinic included a physician, a nurse practitioner, a physician assistant, a registered nurse, 
and three medical assistants. 
Project Design/Methods 
For this DNP project, the clinic team appointed one of the medical staff members 
as the data manager. The data manager was responsible for the review of patients’ 
medical records, data collection for the project, and data storage. Before the start of the 
project, baseline rates of depression screening and diagnosis were obtained by the data 
manager from the electronic medical record. The data manager conducted a retroactive 
electronic chart review on patients 18 years of age and older who had at least one chronic 
disease. These patients needed to have received medical care at the intervention site 
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within a year prior to project initiation. The deidentified data after data collection were 
provided to me for data analysis. 
Before initiating the screening project, I conducted a 30-minute educational 
gathering with the appointed clinical staff, who were called the questionnaire 
administrators (a physician, a nurse practitioner, a physician assistant, a registered nurse, 
and three medical assistants). The session included discussion of the project and its 
purpose and the team’s obligations, which included administering and scoring the PHQ-9 
(Appendix C). The data manager scanned all completed questionnaires in patients’ 
respective medical records, and all PHQ scores were documented electronically. Positive 
questionnaire scores (PHQ-9 > 10) were given to PCPs, who discussed the results with 
participants. 
I received authorization from the host clinic’s Institutional Review Board (IRB) 
as shown in Appendix B to access and analyze internal, deidentified site records deemed 
suitable solely for the doctoral project. I was responsible for conforming with the host 
clinic management’s internal policies and requirements as they related to access and use 
of deidentified site data for the depression screening program. I applied to the Walden 
University IRB for project approval before initiation of the project at the intervention site. 
Patients who met the criteria to participate in the project received an informed consent 
document with the demographic questionnaire (Appendix D). The demographic 
questionnaire included gender, age, race and ethnicity, marital status, education level, and 
yearly income. To maintain patient confidentiality, the data manager used the last four 
digits of the patients’ medical record numbers rather than patient names for data 
collection. Once the project had been initiated by the clinic team, the data manager 
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collected all the deidentified data and kept it locked in a secure drawer within a secured 
room until the end of the screening project. All completed forms were scanned into the 
patients’ electronic health records by the data manager. Moreover, all paper data were 
kept in a secured locker within a secured room for a period of 6 to 9 months and were 
shredded onsite after the entire project was completed and data analysis was finalized by 
me. 
Population and Sampling 
To meet project inclusion criteria, individuals needed to be patients aged 18 years 
or older who received regular medical care at the primary care clinic and who had a 
diagnosis of one or more chronic diseases. Additionally, participants must not have 
received a previous diagnosis of depression. Convenience sampling served as the method 
for selecting healthcare records that met the predetermined criteria. 
Depression Toolkit 
The PHQ-9 guideline by the New York State Department of Health is a national 
guideline that was introduced to the PCPs to determine participants’ severity of 
depressive symptoms (AmeriHealth Caritas Louisiana, 2013). According to the New 
York State Department of Health (2016), no permission is required to use the PHQ-9 
guidelines for health change interventions or programs. With this national guideline, the 
PCP could set up a follow-up visit to confirm the diagnosis, discuss treatment options, 
or/and refer the patient to a mental health specialist. This guideline was not expected to 
substitute for the provider’s clinical judgment; it only represented a source of guidance in 
addition to the provider’s clinical judgment. 
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Data Collection Process 
Instrumentation 
Appendix C shows the instrument used for this project, the Patient Health 
Questionnaire-9 (PHQ-9). The PHQ-9 is a depression module that includes nine 
questions. Scores for the nine questions range from 0 to 27. The questions are answered 
by following the DSM-IV criteria from 0 (not at all) to 3 (nearly every day). The total 
scores determine the severity of depressive symptoms. The PHQ-9 scores are summed to 
indicate the aggregate levels of depression: 
• 0-4: None 
• 5-9: Mild depression 
• 10-14: Moderate depression 
• 15-19: Moderately severe depression 
• 20-27: Severe depression 
Based on the scores, the questionnaire administrators identified positively 
screened patients to their PCPs. The target for a positive screen was a PHQ-9 score of > 
10. Participants with PHQ-9 scores of 10 or higher were considered positive for clinically 
significant depression. A PHQ-9 score of 10 or higher required a follow-up visit to 
confirm the diagnosis and discuss the need for treatment with the PCP. 
The PHQ-9 is reported to function well when used to screen for depressive 
symptoms in patients with chronic diseases (Hinz et al., 2016). Fann et al. (2005) stated 
that regression coefficients were applied to analyze collected data. The PHQ-9 has been 
shown to have 61% sensitivity and 94% specificity when used in adults (Fann et al., 
2005). The PHQ-9 has been tested in a broad range of populations and deemed to be a 
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reliable and valid instrument (American Psychological Association, 2017; Chen et al., 
2016; Spitzer, Williams, & Kroenke, 2014). The PHQ-9 was developed and assessed 
using the traditional psychometric qualities underpinned by CTT (DeVellis, 2006). 
DeVellis (2006) defined CTT as a method that is broadly used for constructing as well as 
evaluating rating scales. The validity of the PHQ-9 instrument has also been established 
in research studies, which have included eight primary care settings and seven obstetrical 
clinics (Gelaye et al., 2013). The PHQ-9 instrument has been identified as a reliable and 
valid tool with remarkable sensitivity and specificity scores (Gelaye et al., 2013). 
Additionally, an item-response theory method to evaluate psychometric properties of the 
PHQ-9 was used to evaluate its psychometric properties as an instrument for measuring 
depression (Gelaye et al., 2013). Their findings established that the instrument is a 
reliable means for assessing depression. 
Ethics and Human Subjects Protection 
Permission was granted by the Walden University IRB (Appendix A) and the 
clinic site (Appendix B) to proceed with data collection. The participants that were 
involved in the study were all adults, aged 18 and older, who had at least one chronic 
disease or more. These patients must have received medical care at the intervention site 
within a year period of project initiation. Participants signed a consent form that 
explained the objectives of the study, its Risks and benefits, study confidentiality, 
participant rights, and information with which to contact the clinic for any further 
questions or clarifications. During the data collection process, the questionnaire 
administrators respected the participants by observing their right to participate in the 
program voluntarily. The depression screening project was explained to the participants 
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extensively to reduce any anxiety or negative feelings among them. The reasons for 
conducting the program at the clinic were fully explained to them. The questionnaire 
administrators applied necessary steps to protect the participants from any breach of 
confidentiality during the data collection process by using the last four digits of the 
participants’ medical record number. There was need for participants to share their 
personal information regarding symptoms of depression, all the deidentified data was 
kept locked in a secure drawer within a secured room until the end of the screening 
project. After the completion of the data collection process, all completed forms were 
scanned into the patient’s electronic health records by the data manager. Moreover, all 
paper data was kept in a secured locker within a secured room for a period of 6 to 9 
months until the entire project was completed, and data analysis has been finalized by 
me. Participants’ confidentiality and anonymity were safeguarded using the health care 
delivery protocol. The program was conducted in a manner that posed no risk to the 
participants. 
Procedure Details for Collecting Data 
The data collection process began immediately after I had secured a letter of 
cooperation from the designated primary care practice where the depression screening 
program was conducted, and from Walden University’s IRB. The depression screening 
procedure was carried out in the examination room while the participant was waiting to 
be seen by their PCP. The questionnaire administrators informed those that were enrolled 
in the program about the purpose of the program to help them understand the significance 
of their participation in the program. In the examination room, the questionnaire 
administrator administered the PHQ-9 individually to those participants that met the 
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criteria for the program. Before the participants started responding to the questionnaire, 
they were asked to read the entire consent form and to indicate that they understood it 
before signing it as a way of indicating their willingness to participate, voluntarily 
without coercion (University of California, Irvine, 2015). 
The participants were also encouraged to take note of any concerns about items in 
the PHQ-9 and were given feedback on any uncertain areas of the questionnaire for 
clarity and understanding. The questionnaire administrators further indicated to the 
participants that if they wished to withdraw from participating in the program, they could 
do so without fear of reprisals from the clinic staff. The participants were then given a 
copy of the PHQ-9 to complete. The participants were instructed to circle their responses 
in the form of numerical scores. The questionnaire administrators calculated the score for 
each item on the PHQ-9 after the completion of the PHQ-9 form by each participant. The 
data manager and the practicum preceptor were involved in the implementation of the 
DNP project; they provided needed explanations and clarifications to facilitate 
completion of the PHQ-9 questionnaire by the participants. The data manager oversaw all 
data, and the practicum preceptor (a physician) monitored and supervised the data 
collection process while I coordinated the program. 
Data Analysis 
After data collection, I was handed de-identified data for data analysis. 
Descriptive statistics were conducted to report the demographic characteristics, the 
prevalence of the PHQ-9 symptoms and how the depression severity symptoms correlate 
with gender. The scores of the PHQ-9 scale were cross-tabulated to report association 
among elevated PHQ-9 scores, categorized chronic illnesses and how those factors 
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interrelate with gender and the daily functionality of the participants. Certain chronic 
medical conditions and participants that scored 10 or higher on the PHQ-9 scale were 
examined to see if there is any contribution to gender. This report guided the PCPs to be 
more cognizant of the signs of depression when caring for this susceptible group. 
A total of 200 participants were asked to participate in the depression screening 
program at the primary care clinic. As shown in Appendix D, the demographic 
characteristics were age, gender, ethnicity, marital status, level of education, and yearly 
income. The age ranges of the sample were 18 and over. Eighty-four (42%) of the 
participants were male and116 were female (58%). There were 109 Caucasians, 75 
African Americans, 3 Hispanics, and 13 participants categorized as other (Appendix G). 
More than 50% of the sample had an education level of high school and below (Appendix 
G). Over 50% had an annual income lower than $30,000 (Appendix G). Table G1 
provides demographic data regarding the participants who were screened. 
Table G2 reports the prevalence of depression severity symptoms by gender. The 
results from this analyzed data demonstrated that 42% (n=84) of the participants had 
minimal depression, 29% (n=57) of the participants had mild depression, 12% (n=23) had 
moderate depression, another 12% (n=24) had moderate-severe depression and 6% (12) 
had severe depression. Apparently, the result illustrated that the more chronic diseases the 
participants suffered from, the more elevated their PHQ-9 scores and the more severe 
their depressive symptoms. 
The other data provided by the participants came from their responses to the nine 
items in the PHQ-9 that measured the symptoms of depression using score columns for 
all nine items on the PHQ-9 scale on Table G3. There is one specific item number on the 
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PHQ-9 scale under which most participants who had more than one chronic condition 
fall. The item question on the PHQ-9 scale was “Trouble falling/staying asleep/sleeping 
too much.” Almost half of the participants screened (n= 98) from a total of 200 
participants acknowledged the presence of this symptom in their daily life (Table G3). 
Table G4 revealed that 0% of depression screening practices and the absence of 
depression screening documentation in the patients’ electronic charts. The post-project 
chart review finding as shown in Table G5 revealed a surprisingly high rate of depression 
diagnosis (17%) in a small sample as small as 200 patients suffering from chronic 
illnesses. Fifteen percent of them were started on antidepressants (Table G5). The DNP 
project depression screening program underscores the importance of focusing on mental 
illness by integrating screening for depression in primary care settings. 
The 200 participants were asked to report how difficult it was to function with the 
problems that they were experiencing daily. As shown in Table G6, of the 200 
participants, 75 (38%) self-reported “Not difficult at all,” 73 (36%) reported “Somewhat 
difficult,” 35 (17%) reported “very difficult” and 17 (9%) “extremely difficult” (Table 
G6). 
Table G7 showed the association between specific medical conditions and how it 
was related to gender. The chronic diseases that were examined included: diabetes, 
hypertension, heart disease, kidney disease, COPD/asthma, arthritis, and dyslipidemia. 
Other chronic diseases were fibromyalgia, thyroid conditions, multiple sclerosis, cancer, 
and psychiatric disorders. Table G7 revealed that many participants were primarily 
affected by diabetes (14.5%), dyslipidemia (29.5%), arthritis (18%), and by other chronic 
conditions (19%) as mentioned above. 
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Many of the participants with one to two chronic conditions scored lower on the 
PHQ-9 scale compared to participants that had two or more chronic illnesses. As shown 
in Table G8, out of the 84 male participants that were screened for depression, a total of 
43 male participants were identified to have more than two chronic medical conditions, 
out of those 43 male participants, almost half of the participants self-reported a PHQ-9 
higher than 10. Likewise, for the female participants on Table G9. Out of the 116 female 
participants that were screened for depression, a total of 72 female participants were 
identified to have more than two chronic medical conditions. Out of those 72 female 
participants, 37 participants which accounts for more than half of those screened self-
reported a PHQ-9 higher than 10 (Table G9). 
Project Evaluation Plan 
This primary care clinic offered an exceptional privilege to introduce and 
integrate an evidence-based quality improvement program to screen out patients who are 
at risk of depression. The goal of this program was to implement an evidence-based 
depression tool in this primary care setting for all patients with one or more chronic 
diseases presenting to the clinic for primary care services. As such, there was a paucity of 
research on routine screening for depression among the general adult population. This 
project attempted to bridge this gap. 
A strategy used in this project toward improving outcomes and quality of health 
care for this project was an interdisciplinary teamwork approach. The clinic team 
assumed full responsibility for this screening program to administer, score, and interpret 
results of the assessment tool, including diagnosis, treatment options, and referrals. The 
scope of this screening project was to implement change by initiating an assessment tool 
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at the primary care clinic to identify depression early in patients who had chronic 
diseases. The intention was to establish a depression screening procedure at the clinic site 
using the PDSA model as a framework to initiate quality improvement process (Donnelly 
& Kirk, 2015). The PCPs discussed the PHQ-9 scores with all identified patients who had 
positive screens (PHQ-9 scores > 10) and then intervened accordingly. The 
interdisciplinary team approach involved a partnership with other healthcare 
professionals, in this case, mental health specialists, PCPs with other health support 
personnel, which formed a community of health care providers to address the mental 
health issue. This collaboration promoted depression management programs. Prior 
research in randomized clinical trials has revealed that individuals with medical 
comorbidities do benefit from screening for depression so that their depression can be 
proactively managed using integrated care methods (Coventry, Lovell, Dickens, & 
Bower, 2015). 
A Cochrane review that involved 79 randomized clinical controlled trials found 
that collaborative care is more effective than the usual care for depression (Archer, 
Bower, Gilbody, & Lovell, 2012). This project was of benefit to the clinic because it 
provided ideas and information for expanding services to include routine depression 
screening. It encouraged and developed the interdisciplinary relationships with other 
healthcare professionals, such as mental health professionals and chronic disease 
specialists. The introduction of screening for depression risks was also used as a quality 
measure for the clinic. 
The state of Maryland has established the Center for Community Collaboration 
through which the state has designed a program known as screening, brief intervention, 
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and referral to treatment (SBIRT), which is focused on dissemination of screening, brief 
intervention, and referral to treatment for mental disorders that include depression. 
However, the screening process remains alarmingly low in the primary care settings in 
this state. Thus, the need for projects such as this doctoral project continues to sensitize 
the primary care health community to the necessity of screening for mental disorders. 
The retention of accurate research data and findings was significant because these 
screening data could be used to answer questions about the phenomenon being examined. 
They could also be used to answer the project question and to identify areas of further 
research and to frame new techniques and approaches to improve health practice. 
Summary 
Depression is a pervasive mental health disorder across the world. In the United 
States, depression accounts for 3.7% of all U.S. disability-adjusted life years and 8.3% of 
all U.S. years lived with disability (National Institute of Mental Health, 2015). 
Depression is also a leading causative factor for disability. Research has demonstrated 
that being diagnosed with chronic illnesses can exacerbate susceptibility to depression 
(Unützer & Park, 2012). The Taylor et al. (2015) claim that despite the significant 
prevalence of depression in the United States, the detection and subsequent treatment of 
comorbid depression in primary care settings remains suboptimal. In the state of 
Maryland, 3.0% of all adults are reported to have depressive symptoms each year 
(Hedden et al., 2015). That is, about 130,000 people have depressive symptoms each year 
and this does not include asymptomatic individuals (Hedden et al., 2015). Apparently, 
there is need to initiate proactive measures by implementing routine screening in primary 
care settings. As previously reported, current literature indicates that screening improves 
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detection, diagnosis, treatment outcomes (Culpepper et al., 2015). This project 
endeavored to improve early detection of depression among patients with chronic 
diseases in a primary care setting to pave the way for proactive management of 
depression using integrated care method. 
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Section 4: Findings and Recommendations 
Introduction 
Depression is a widespread mental health condition across the world (WHO, 
2014). It is a leading causative factor for disability (Maryland Department of Health and 
Mental Hygiene, 2014). The doctoral project was conducted at a suburban primary care 
clinic located in the eastern part of Maryland. The average resident at this location was at 
greater risk for suffering from chronic diseases compared to the national average because 
of disparities in access to health care services and preventive resources (Maryland 
Department of Health and Mental Hygiene, 2014). 
According to the Maryland Department of Health and Mental Hygiene (2014), in 
the state of Maryland, 3.0% of all adults are reported to have depressive symptoms each 
year. That is, about 130,000 people have depressive symptoms each year (Hedden et al., 
2015). This figure does not include asymptomatic individuals. There is a need to initiate 
proactive measures by introducing and implementing a depression screening tool at the 
designated primary care clinic. Current literature indicates that screening improves 
detection, diagnosis, and treatment outcomes (Culpepper et al., 2015). This project 
involved an effort to implement early detection of depression among patients with 
chronic diseases in a primary care setting to pave the way for proactive management of 
depression using integrated health care methods. 
Research indicates that there is a 15.6% risk of depression among individuals with 
chronic conditions such as asthma, COPD, arthritis, heart disease, and osteoporosis 
(Bhattacharya et al., 2014). Maryland is in the second unhealthiest region in the United 
States (Maryland Department of Health, n.d.). The adjusted rate of cardiovascular disease 
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in Maryland by race is 50.3% for African American men, 45.2% for African American 
women, 34.8% for Caucasian women, and 33.5% for Caucasian men (Maryland 
Department of Health, n.d.). 
The DNP project’s objective was to close the existing gap in the delivery of 
primary care services, which has mostly excluded screening for depression at the 
practicum site, a primary care clinic located in Maryland. Research shows that two-thirds 
of adults seen in primary care remain undiagnosed with depression (Pence, O’Donnell, & 
Gaynes, 2013). This project fostered early detection of comorbid depression among 
patients with chronic diseases following the implementation of routine screening for 
depression at this primary care setting. The project enhanced the roles played by nurses 
as leaders to bring forward screening procedures in primary care settings. 
The clinic had no routine depression screening practices in place at baseline. 
Despite the PCPs’ expertise in managing an array of health conditions at the clinic site, 
there was an absence of screening for depressive symptoms. The evidence came from the 
clinic’s data, as presented in a baseline report that revealed 0% for depression screening 
practices and the absence of depression screening documentation in electronic medical 
charts. In light of this information, it was important to identify a reliable tool that would 
be used to screen depression among patients with chronic diseases at this primary care 
clinic. 
Project Summary and Evaluation Report 
PCPs are skilled in managing various diseases in their practices. However, their 
patients are often not screened for depression; this lack of screening represents a 
significant gap in the healthcare delivery system. The results of the program can be used 
33 
 
 
not only to encourage other PCPs to adopt integration of routine screening for depression 
but also to lobby for more aggressive depression screening policy guidelines and to make 
depression a priority preventive practice in the healthcare industry. Because of the 
evidence obtained from the depression screening program, other PCPs will be motivated 
to become significant advocates for screening and for promoting depression awareness in 
their practices and communities. As an evaluator for the depression screening program at 
the designated primary care clinic, I supervised and functioned within the context of the 
PDSA model and ensured that all cycles of the model were completed to evaluate the 
effectiveness of the model (Moore et al., 2014). The program evaluation process involved 
synthesizing information about the data collection activities and outcomes of the program 
to evaluate the program’s effectiveness and make improvements (Moore et al., 2014). 
Furthermore, the evaluation process helped assess the impact of the depression 
screening program on the target population group. As an evaluator, the depression 
screening program was also assessed to confirm that the program was in alignment with 
the purpose for which it was designed. This means that the PDSA model was used to 
guide the questionnaire administrators to promote quality improvement (QI) at the 
primary care clinic. 
The PDSA model diagram (Appendix E) is structured in such a way that it tests a 
change that is implemented. It does this through four prescribed steps that guide it and 
break down the task of accomplishing the specified steps (Taylor et al., 2015). As shown 
in Appendix E, the PDSA model was chosen for that purpose, as it focused on the root of 
change and the translation of the intervention (Reed & Card, 2015). The PDSA model is 
very appropriate for QI interventions that involve testing changes (Taylor et al., 2015). 
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Plan 
At this initial stage, the few clinical staff were appointed as “questionnaire 
administrators.” I conducted a 30-minute in-service session with the appointed staff to 
educate them on depression screening program details, the PHQ-9, the PDSA model, and 
the program’s purpose, objectives, and goals. The DNP student reinforced and clarified 
what each staff member’s duties were to ensure that all appointed staff were aware of 
their roles in relation to the depression screening project. 
Do 
At this stage, the actual data collection process was conducted. Participants were 
screened in the examination room while they were waiting to be seen by their PCP. I 
continued to collaborate with the appointed staff and ensured that all activities were 
reviewed and monitored. This helped in pinpointing deficiencies so that improvements 
could be made when needed. All activities of the entire program were examined and 
evaluated. The screening process constituted the “study” part of the model. 
Study 
During this stage, I reviewed the objectives and purposes of the depression 
screening program as well as information gathered from preceding phases to determine 
whether the program resulted in the anticipated improvement and whether the entire 
project was worth the effort and investment required. I assessed activities of the program 
through the data manager. One of the challenges was to determine the best way to 
distribute the questionnaires while maintaining the confidentiality of the participants. The 
clinic team was advised by me to put the questionnaires in a manila envelope before 
giving them out to the participants. Some participants had low literacy skills; they had 
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trouble understanding what the questions meant. That issue was addressed by assisting 
those participants with reading the questions, as well as simplifying the questions so that 
they would not feel uncomfortable due to their inability to read and understand the PHQ-
9 (Appendix C). Furthermore, the questionnaire administrators came across some 
participants who were identified as positive screenings for depression (PHQ-9 scores > 
10). Those participants were counselled on depression, and benefits of follow-up care 
were discussed with them for proper evaluation. 
After data collection, the data manager handed over 200 completed PHQ-9 forms 
with deidentified coded data to me after which I evaluated the data. The descriptive 
statistical analysis was conducted to determine how effective the PHQ-9 is as a 
depression screening tool. All information obtained was used as part of the evaluation 
process to address all unanticipated problems. 
Act 
At this phase of the program, I reviewed the entire program using the PDSA 
model to note where improvement was needed. Some recommendations were made to the 
clinical staff because the screening process will be an ongoing process as the program 
continues following the implementation of the depression screening intervention. The 
leaders of the primary care clinic are considering adopting this change into the practice. 
The clinic staff plan to screen for depression at least once a year for all returning patients; 
all new patients will be screened during their first visit to the clinic. The PDSA model 
will continue to improve quality through this project at this intervention site regarding 
screening for comorbid depression. Additionally, the staff at the intervention site may 
make changes to the program that has been implemented. 
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Summary and Evaluation of Findings 
PCPs are in optimal positions to screen, identify, diagnose, treat, follow up with 
and refer patients to psychotherapy counselling or psychiatrists. The depression screening 
intervention was conducted in a designated primary care setting. The PHQ-9 was used to 
obtain data from the patient participants regarding depression and provided a means of 
scoring patients’ depressive status. Descriptive data analysis was conducted by me to 
provide evidence for the findings. Other data that were gathered included participants’ 
ethnicity, gender, age, level of education, marital status, and income level. The 
depression screening intervention was implemented among 200 patients at a designated 
primary care clinic in Maryland. After the participants signed the consent form indicating 
their willingness to participate in the program, a questionnaire was distributed to them. 
After clinic registration, the PHQ-9 (Appendix C) from the New York State Department 
of Health (2016) was administered to patients who consented to participate. According to 
the depression toolkit (Appendix F), scores of 0 to 4 on the instrument meant that 
individuals had minimal depressive symptoms and needed no intervention (see Appendix 
F). Questionnaire scores of 5 to 9 were indicative of mild depression; in such cases, 
patients needed to be watched closely in case the condition progressed (Appendix F). No 
psychotherapy was needed at this stage. Scores of 10 to 14 suggested moderate 
depression. A score of 15 to 19 suggested a diagnosis of moderately severe depression 
(Appendix F). Scores of 20-27 indicated severe depression (Appendix F). 
Discussion of Findings 
Depression is recognized as a major health problem that impacts both the mental 
and physical health of people living with chronic diseases. This DNP project generated 
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more evidence to support the need for regular screening for diagnosis and treatment of 
depression among patients suffering from chronic diseases. The PHQ-9, which is a 
depression module that includes nine questions, was manually completed by participants, 
who circled their responses in the form of numerical scores. The questionnaire 
administrators (a physician—practicum preceptor, a nurse practitioner, a physician 
assistant, a registered nurse, and three medical assistants) provided needed explanations 
and clarifications to facilitate completion of the PHQ-9 questionnaire by the participants. 
The questionnaire administrators calculated a score for each item after each participant’s 
completion of the PHQ-9 form. The completed forms were scanned into the patient’s 
electronic health record, and the PHQ-9 scores were documented electronically by the 
data manager. These scores were used as measures to help in understanding depression 
outcomes for better monitoring and treatment of depression. 
This project functioned to create awareness among PCPs of the importance of 
identifying and treating depression in patients suffering from chronic diseases and to 
ensure that depressive symptoms are reduced and better managed. The PCPs in the study 
were in optimal positions to screen, identify, diagnose, treat, follow up with, and refer 
patients to psychotherapy counseling or psychiatrists. No permission is required to use 
the PHQ-9 guidelines for health change interventions or programs. Total PHQ-9 scores 
determine the severity of depressive symptoms. The PHQ-9 scores were summed to 
indicate aggregate levels of depression, as follows: 0-4: none, 5-9: mild depression, 10-
14: moderate depression, 15-19: moderately severe depression, and 20-27: severe 
depression.  The depression severity symptoms findings in this study reveal that 42% (n = 
84) of the participants had minimal depression, 29% (n = 57) had mild depression, 12% 
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(n = 23) had moderate depression, another 12% (n = 24) had moderate-severe depression, 
and 6% (n = 12) had severe depression (Table G2). A very interesting finding was that 
the postproject chart review revealed a surprisingly high rate of depression diagnosis at 
17% for such a small sample size of 200 patients suffering from chronic illnesses (Table 
G5). 
Based on the PHQ-9 scores, patients considered positive for clinically significant 
depression with a PHQ-9 score > 10 were identified by the questionnaire administrators. I 
provided the PCPs with a depression toolkit that contained guidelines for using the PHQ-
9 from the New York State Department of Health (2016). These guidelines described 
various courses of action depending on patients’ PHQ-9 scores. The PHQ-9 scores were 
translated to actual diagnoses; for example, PHQ-9 scores of 10-14 required that the PCP 
propose treatment and counseling to the patient, whereas PHQ-9 scores of 20-27 
represented severe depression and required the PCP to pursue immediate initiation of 
treatment and expedite referral of the patient to a mental health facility. The patients were 
referred to their PCPs, who discussed the results and counseled them on depression and 
the benefits of follow-up care for proper evaluation. The PCPs then set up follow-up 
visits to confirm the diagnoses, discuss treatment options, or/and refer the patients to 
mental health specialists. During the follow-up visit, the PCPs discussed the PHQ-9 
scores with the patients who had positive screens (PHQ-9 scores > 10) and then advised 
them accordingly. The PCPs undertook an interdisciplinary team approach that involved 
partnerships with other healthcare professionals, including mental health specialists, to 
address the mental health issues, which promoted depression management programs for 
patients.  
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The scope of this DNP project encompassed implementing change through the 
initiation of an assessment tool at the primary care clinic that helped with the early 
identification of depression in patients suffering from chronic diseases. This assessment 
did not serve as a substitute for the patients’ initial clinical judgment; it only acted to 
provide additional information to inform the initial clinical judgment. I pursued this study 
in an effort to guide the PCPs to be more cognizant of the signs of depression when 
caring for patients with chronic diseases because the clinic initially had no routine 
depression screening practices in place. Routine screening would increase rates of 
diagnosis and treatment of depression while contributing to patients’ self-management 
practices. 
The study findings reveal that routine screening for depression among patients 
suffering from chronic depression is important. The depression screening program will 
help PCPs realize the need for routine screening will enhance their knowledge and 
understanding of mental health. In addition, their healthcare practices will improve, and 
they will be in a position to mitigate the deleterious effects of patient depression. In 
realizing the need for routine screening, PCPs can become leaders in fighting morbidity 
and mortality associated with depression through early detection and treatment.  
Implications 
The unanticipated outcomes of the depression screening findings, as shown in 
Table G5, included a surprisingly high rate of definite depression diagnosis (17%). A 
total of 34 participants were newly diagnosed with depression (Table G5). A total of 30 
participants (15%) were started on antidepressants (Table G5), while four participants 
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(2%) refused treatment and 60 participants (30%) scored 10 or greater on the PHQ-9 
questionnaire and were identified as positive screens. It was surprising to see a definite 
depression diagnosis percentage of 17%, which was higher than the state figure of 15%. 
About 6% of depression diagnosis was indicated by research conducted by Bhattacharya 
et al. (2014). In other words, the findings of this DNP project may indicate that the 
percentage of depression is higher in the state than initially believed. 
The high percentage of depression among the 200 participants in this DNP project 
suggested that there is a need to integrate screening for depression in primary care 
settings. The aim is to be able to identify patients with depression who need access to 
treatment to mitigate morbidity and enhance patient outcomes. Patients with moderately 
severe depressive symptoms and severe depressive symptoms need to be monitored to 
ensure that their condition remains under control. The successful detection of depression 
in the designated primary care setting is significantly important due to the complex 
interaction between mental and physical health. Primary care institutions, particularly 
those serving less advantaged communities, can serve as gateway institutions for access 
to collaborative care for patients. 
The outcomes of the depression screening intervention show that it is possible to 
petition the healthcare industry to make screening for depression a standard of care. 
Doing so will make it easier for people suffering from depression to be screened so that 
depressive symptoms can be detected early, which is imperative for the development of 
healthy and productive communities. PCPs can help to reduce mental health disparities in 
the target populations and increase awareness of depression in the community. The 
project has positive implications for social change, in that the primary aim was to 
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introduce and integrate evidence-based routine screening for depression, which was 
introduced and facilitated appropriately in the diagnosis of identified patients. The project 
supports the recommendation that timely and accurate diagnosis of depression is initiated 
in primary care institutions to have positive health outcomes for patients with depression. 
Project Strengths and Limitations 
A limitation of the depression screening program is that the questionnaire 
administrators only used one screening instrument, the PHQ-9, for data collection. It may 
have been more beneficial to use more than one instrument to compare its efficacy 
toward detecting depressive symptoms in this and other target population. 
Another limitation of the project is that our sample consisted of only 200 
voluntary participants recruted from only one primary care setting as a captive sample. 
As such, it is not known how well the findings could be generalized to the general 
population at the state or national levels. Therefore, a generalization of the results should 
be conducted with caution. Since depression can affect memory, it is possible that some 
participants were not able to recall some of their symptoms. However, the PHQ-9 
questions used to collect information were structured in a way that helped participants 
remember how they felt to provide relevant information for the project (Moore et al., 
2014). Furthermore, our timeline for completing the project only permitted the appointed 
clinic team to implement interventions at one institution. Nevertheless, our findings have 
contributed to the argument that there is a need for integration of screening for depression 
in primary care settings. The project findings are also consistent with the literature on 
screening for depression in primary care (Robinson et al., 2008). By addressing these 
issues, the health care delivery system could improve the quality of patient-centered care 
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through early identification and diagnosis of depression and could improve outcomes 
(Robinson et al., 2008). The instrument that was used in the project has a high sensitivity 
and specificity and has been validated and frequently used in studies for depression 
screening. 
On Tables G8 and G9, the tool identified patients with multiple chronic diseases 
to have severe depression. The more chronic diseases they had, the more they were likely 
to have severe depression (Walker et al., 2014). There was no statistical analysis done, 
only descriptive statistics. Also, there was no control group used for comparison. Hence, 
it was difficult to tell if there existed a statistically significant relationship. However, the 
following calculation was done - the mean for the prevalence of PHQ-9 symptoms among 
the patients (μ = (Σ Xi ) /n) was 19 for males and 32.5 for females. This means that the 
prevalence of PHQ-9 for depression was almost double for females compared to their 
male counterparts. The mode was 38 for males and 60 for females. Standard Deviation 
(SD) = 13.51). 
Contribution of the Doctoral Project Team 
I was the overseer for the implemented project at the designated primary care 
clinic. I worked with the questionnaire administrators of the primary care practice. The 
questionnaire administrators were: one physician (practicum preceptor), one nurse 
practitioner, a registered nurse (data manager) and three medical assistants). The 
appointed clinical staff known as the questionnaire administrators identified patients who 
were suffering from chronic diseases, met the project criteria and were willing to 
participate in the study. The questionnaire administrators administered both the PHQ-9 
form and the demographic questionnaire (Appendix D) to the participants. The 
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questionnaire administrators also collected information about the gender, race or 
ethnicity, marital status, and race of the participants. When the participants had 
completed the questionnaires, they were collected and given to the project data manager 
for coding and storage. The project team assessed and evaluated the need for screening 
for depression before approving it. The data manager provided the necessary guidance 
and facilitation for designing and implementing the program at the designated practice, 
under the auspice of me and the practicum preceptor. 
The implemented program should be extended beyond its current location; there 
is a need to reach out to other PCPs, the psychiatric community, and the mental health 
community to adopt the depression screening program. It will create an opportunity to 
work as an integrated, interdisciplinary team to encourage routine depression screening, 
diagnosis, and treatment, particularly among population groups suffering from chronic 
diseases. This way, it is possible to lobby insurance carriers to cover screening services 
and ensuing treatment modules. 
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Section 5: Analysis of Self 
As a professional and doctorate nursing student leading the depression screening 
program at the practicum site, I served as the content expert for the program. I introduced 
an existing instrument, the PHQ-9 tool, to the clinic staff to screen and detect for 
depression symptoms. The tool guided the questionnaire administrators to collect data 
from patients suffering from chronic diseases. By providing scholarly and relevant 
information about the tool to the staff, I was able to coordinate and facilitate the 
implementation of the depression screening program at a designated primary care clinic 
located in Maryland. 
Summary and Conclusions 
The collaborative effort to disseminate the findings of my DNP project will target 
the potential adopters of the findings at the practicum site where the program was 
conducted. As a team, the clinic staff and I will target other primary care settings, 
integrated delivery systems, healthcare insurance companies, and independent practice 
associations. We will endeavor to disseminate these findings as a team and report 
evidence from the program to audiences such as healthcare professionals across the 
board, policymakers, and community leaders as well as psychiatry professionals using 
professional publications, the media, and seminars. As a team, we will also target PCP 
consortia. 
It has been reported by the U.S. Preventive Services Task Force (2016) that 
depression is among the leading causes of disability among people aged 15 and above. As 
such, its multifaceted deleterious effects touch families, industries, and society. By 
considering the persistent pain associated with chronic health conditions, it becomes 
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necessary for nursing leaders to conduct a project that assesses the prevalence of 
depression among individuals suffering from chronic diseases. My implemented program 
indicated that there was a significant rate of depression among the population group 
studied. Based on the program findings, the clinic team and I believe that it is necessary 
for primary care practices to integrate depression screening into the primary care setting. 
It is essential to work closely with clinicians at the primary care clinics to disseminate the 
findings of the program and thus increase awareness of the need to screen for depression 
in people with chronic illnesses. 
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Appendix A: Walden University IRB Approval 
Project approval was granted by the Walden University Institutional Review 
Board on September 12, 2017. The approval number to proceed with the DNP Quality 
Improvement Evaluation is 0568309. 
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Appendix B: Site Approval 
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Appendix C: PHQ-9 
  
Patient 
Name 
 Date   
 
1. Over the last 2 weeks, how often have you been bothered by any of the 
following problems? Read each item carefully and circle your response. 
 
 Not 
at all 
Several 
days 
More 
than 
half the 
days 
Nearly 
every 
day 
 0 1 2 3 
a. Little interest or pleasure in doing things     
b. Feeling down, depressed, or hopeless     
c. Trouble falling asleep, staying asleep, or 
sleeping too much 
    
d. Feeling tired or having little energy     
e. Poor appetite or overeating     
f. Feeling bad about yourself, feeling that 
you are a failure, or feeling that you have 
let yourself or your family down 
    
g. Trouble concentrating on things such as 
reading the newspaper or watching 
television 
    
h. Moving or speaking so slowly that other 
people could have noticed. Or being so 
fidgety or restless that you have been 
moving around a lot more than usual 
    
i. Thinking that you would be better off 
dead or that you want to hurt yourself in 
some way 
    
Totals     
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Developed by Drs. Robert L. Spitzer, Janet B.W. Williams, Kurt Kroenke, and 
colleagues, with an educational grant from Pfizer Inc. No permission required to 
reproduce, translate, display, or distribute. 
 
  
 
2. If you checked off any problem on this questionnaire so far, how difficult have 
these problems made it for you to do your work, take care of things at home, or 
get along with other people?  
    
Not Difficult at All Somewhat Difficult Very Difficult Extremely 
Difficult 
0 1 2 3 
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Appendix D: Demographic and Background Characteristics Questionnaire 
Gender: a. Male  b. Female 
Age:  a. 18-30  b. 31-40  c. 41-50 d. 51-59 
  e. 60-70  f. 71+ 
Race and Ethnicity: a. Non-Hispanic/ Caucasian  b. African American   
c. Hispanic/Latino d. Other 
Marital Status: a. Single  b. Married   c. Separated    
d. Widowed e. Divorced   f. living together 
Level of Education: a. Less than a high school diploma b. High school diploma  
c. Some college or Associate’s degree  d. Bachelor’s degree 
e. Postgraduate degree 
Yearly Income: a. Under $10,000 b. $10,000 - $19,999 c. $20,000 - $29,999 
c. $30,000 - $39,999 d. $40,000 - $49,999 e. $50,000 - $74,999 
f. $75,000 - $99,999 g. over $100,000 
Medical Conditions: a. Diabetes  b. Blood Pressure c. High Cholesterol  
d. Kidney disease e. Heart disease f. COPD/Asthma 
g. Arthritis h. Other  (Circle all that apply) 
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Appendix E: PDSA Model Diagram 
 
Note. This diagram was used to guide depression screening intervention and to interpret 
data findings to the clinic team. The PDSA diagram is in Open Access and can be 
accessed at any time. No permission is required to reproduce, translate, or display 
provided that appropriate citation is used (Perry, Bell, Fitzpatrick & Sampson, 2014). The 
model was also used as a framework for the project’s evaluation process. 
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Appendix F: Depression Toolkit Contents 
Guidelines for using PHQ-9 from New York State Department of Health (2016) 
PHQ-9 Depression Severity Score  Proposed Treatment Actions 
0-4 Minimal     No treatment recommended 
5-9 Mild depression Watch the patient closely just in case 
it progresses. No recommended 
treatment at this stage. 
10-14 Moderate depression Propose treatment and counseling 
15-19 Moderately severe depression Patient needs active treatment- 
pharmacotherapy and psychotherapy 
20-27 Severe depression Requiring immediate initiation of 
treatment; expedite referral to a 
mental health specialist. 
 
(New York State Department of Health, 2016) 
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Appendix G: Cross-Tabulations of Descriptive Statistics Data 
Table G1 
Demographic Characteristics of Screened Participants 
Variables No of participants screened Percentage 
Gender   
Male 84 42% 
Female 116 58% 
Age Male Female 
18-30 14 16 
31-40 16 24 
41-50 16 23 
51-59 19 24 
60-70 15 18 
71+ 4 11 
Ethnicity Male Female 
Caucasian 52 (26%) 57 (29%) 
African American 27 (14%) 48 (24%) 
Hispanic/Latino 2 (1%) 1 (< 1%) 
Other 3 (2%) 10 (5%) 
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Table G2 
Demographic Characteristics of Screened Participants 
Marital status Male Female 
Single 36 44 
Married 31 42 
Separated 1 9 
Widowed 5 6 
Divorced 7 11 
Living together 4 4 
Level of education Male Female 
< High school diploma 8 12 
High school diploma 45 52 
Associate’s degree 22 37 
Bachelor’s degree 7 8 
Postgraduate degree 2 3 
Yearly income Male Female 
Under $10,000 13 27 
$10,000 to $19,999 16 25 
$20,000 to $29,999 12 19 
$30,000 to $39,999 6 14 
$40,000 to $49,999 13 13 
$50,000 to $74,999 11 10 
$75,000 to $99,999 10 3 
Over $100,000 3 5 
 
Prevalence of Depression Severity Symptoms by Gender 
 
 
 
Table G3 
Range of PHQ-9 Scores 
 N (%) Males Females 
0-4 Minimal 42% 40 44 
5-9 Mild depression 29% 23 34 
10-14 Moderate depression 12% 7 16 
15-19 Moderately severe 12% 12 12 
20-27 Severe depression 6% 2 10 
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Table G4 
Prevalence of PHQ-9 Symptoms by Gender 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PHQ-9 item N Males Females 
1. Little interest/pleasure in doing things 63 23 40 
2. Feeling down/depressed/hopeless 48 14 34 
3. Trouble falling/staying asleep/sleeping too much 98 38 60 
4. Feeling tired/little energy 
 
79 33 46 
5. Poor appetite/overeating 62 18 44 
6. Feeling bad about self/that you are a failure/ 
have let yourself down/let your family down 
32 12 20 
7. Trouble concentrating (reading newspaper 
or watching television) 
43 17 26 
8. Moving or speaking so slowly that other 
people notice/Or opposite: fidgety/restless/ 
moving around a lot more than usual 
32 9 23 
9. Thoughts that you would be better off dead/ 
or of hurting yourself in some way 
6 4 2 
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Table G5 
Preproject Chart Review (N = 200) 
Number of patients screened 
before intervention 
Number of patients 
screened after intervention 
0 200 
 
Table G6 
Postproject Chart Review Findings: Total Participants Screened (N = 200) 
No. of Patients Positive PHQ-9 Diagnosed with Started on 
screened  (score > 10)  depression  antidepressants 
200   60 (30%)  34 (17%)  30 (15%) 
Note. Four participants refused depression treatment—religion and personal reasons. 
 
Table G7 
Association Between PHQ-9 Scores and Daily Functionality 
 
 
Not difficult at all Male Female Total 
number of 
participants 
(N) 
Percentage 
(%) 
Somewhat difficult 32 43 75 38% 
Very difficult 34 39 73 36% 
Extremely difficult 14 21 35 17% 
Not difficult at all 4 13 17 9% 
Note. The question was “How difficult have these problems made it for you to do 
your work, take care of things at home, or get along with other people?” 
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Table G8 
Association Between Specific Chronic Medical Conditions and Gender (N=200)  
Medical conditions Male    % Female   % 
Diabetes 5% 10% 
Hypertension 15% 15% 
Dyslipidemia 4% 4% 
Kidney disease < 1% 1% 
Heart disease 2% 2% 
COPD/asthma 2% 5% 
Arthritis 5% 13% 
Other chronic conditions (fibromyalgia, thyroid 
conditions, multiple sclerosis, cancer, and psychiatric 
disorders) 
9% 10% 
 
Table G9 
 
Association Between Elevated PHQ-9 Scores and Characterized Chronic Illnesses in 
Males 
 
Category for 
comorbid chronic 
diseases 
 
Male PHQ-9 
score 
below 10 
PHQ-9 score 
between 10-
14 
 
PHQ-9 score 
between 15-
19 
PHQ-9 score 
between 20-
27 
1 chronic 
condition 
41 40 1 0 0 
 
1-3 chronic 
conditions 
 
17 
 
7 
 
3 
 
7 
 
0 
 
Over 3 chronic 
conditions 
 
26 
 
17 
 
2 
 
5 
 
2 
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Table G10 
 
Association Between Elevated PHQ-9 Scores and Characterized Chronic Illnesses in 
Females 
 
Category for 
comorbid 
chronic 
diseases 
Female PHQ-9 
score 
below 10 
PHQ-9 score 
between 10-
14 
PHQ-9 score 
between 15-
19 
PHQ-9 score 
between 20-
27 
1 chronic 
condition 
 
44 41 3 0 0 
1-3 chronic 
conditions 
 
30 19 5 4 2 
Over 3 chronic 
conditions 
42 16 9 11 6 
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Appendix H: Scholarly Product for Dissemination 
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